Targeting Cancer with Antibody-drug Conjugates » ADC Review sorted by
relevance

Admin14.09.2021

Targeting Cancer with Antibody-drug Conjugates » ADC Review

5706
Admin11.08.2021

Figure 1 from Antibody-drug conjugates: recent advances in

5805
Admin21.09.2021

ADC technology

4308
Admin30.07.2021

Antibody-Drug Conjugate (ADC) and Cancer Therapy

9100
Admin26.08.2021

[PDF] Antibody drug conjugates: Progress, pitfalls, and

9109
Admin23.07.2021

Pharmaceuticals | Free Full-Text | Antibody-Drug

7409
Admin14.08.2021

Antibody-drug Conjugate Development » ADC Review

8201
Admin25.09.2021

Antibody Drug Conjugates for Cancer Therapy

9201
Admin10.08.2021

The Clinical Landscape of Antibody-drug Conjugates - ADC

Admin26.08.2021

Biomedicines | Free Full-Text | Antibody-Drug Conjugates

9010
Admin24.08.2021

Antibodies | Free Full-Text | Antibody Drug Conjugates as

9905
Admin27.07.2021

CPhI Annual Report 2018: ADCs Growth Driven by Lack of In

9608
Admin24.08.2021

The ABCs of ADCs: A Review of Antibody Drug Conjugates

5308
Admin13.08.2021

Antibody Drug Conjugates for Cancer Therapy

9407
Admin02.09.2021

Antibody-Drug Conjugates: Future Directions in Clinical

9602
Admin10.10.2021

[Full text] Antibody-drug conjugates: targeted weapons

2002
Admin05.08.2021

Seattle Genetics Launched the Phase II Clinical Trial of

500
Admin25.09.2021

Schematic for the structure of an antibody-drug conjugate

7107
Admin22.08.2021

Targeting Cancer with Antibody-drug Conjugates » ADC Review

9402
Admin02.10.2021

Antibodies | Free Full-Text | Antibody Drug Conjugates as

3601
Admin19.07.2021

Schematic illustration of antibody-drug conjugate (ADC

702